Escolar Documentos
Profissional Documentos
Cultura Documentos
Dodik Tugasworo
PENYAKIT SARAF
NYERI
SAKIT KEPALA
MIGREN
VERTIGO
KESEMUTAN
PARKINSON
EPILEPSI
INFEKSI OTAK
GANGGUAN INGATAN
GANGGUAN PERKEMBANGAN ANAK
GANGGUAN GERAK
TUMOR OTAK
GEGAR OTAK
PIKUN BUYUTAN
STROKE
APAKAH STROKE ?
SUHARTO
GUS DUR
MENDADAK
MENCEMASKAN
MENAKUTKAN
MENGGELISAHKAN
KESEMBUHAN
KECACATAN
KEMATIAN
STROKE
direct-costs $ 27 billion
Ischaemic
Recovery
Haemorrhagic
Force discharge
Death
BATASAN STROKE
W.H.O 1986 memberikan batasan sbb ;
Suatu TANDA-TANDA KLINIS
yang
BERKEMBANG
CEPAT
akibat
GANGGUAN FUNGSI - OTAK FOKAL
atau GLOBAL dengan GEJALA GEJALA
yg berlangsung 24 jam atau lebih /
menyebabkan KEMATIAN tanpa sebab
lain selain VASKULER
O T A K
BERAT :
1200 - 1400 GRAM
(2 % BB)
KUMPULAN
PUSAT-PUSAT
TUGAS BERAT
PERLU MAKANAN YANG CUKUP
DAN TERATUR
TIAP MENIT : 800 CC OKSIGEN
100 MGR GLUKOSA
TERHENTI
30 DETIK
TERHENTI
3 MENIT
TERHENTI
8 MENIT
SEL TERGANGGU
SEL MATI
KECACATAN
MENINGGAL
3
1
3
2
Syndrome Localization
-----------------------------------------------------------------------------------------------------------------
R. (NONDOMINANT) HEMISPHERE
(Major or branch cortical infarction)
- Aphasia
- Left hemiparesis
- Right hemiparesis
BRAIN STEM
- Motor or sensory loss
four limbs.
- Crossed signs (signs on
side of face/other side
- Dysconjugate gaze.
- Nystagmus ; Ataxia.
- Dysarthria; Dysphagia.
FAK T O R
RISIKO
FAKTOR
PENCETUS
STROKE
(GANGGUAN PEREDARAN DARAH OTAK)
TERGANTUNG
DOKTER
PADA KECEPATAN
SPESIALIS
SARAF
BEROBATNYA
SEMBUH
SEMPURNA
MENYANDANG
CACAT
MENINGGAL
Keluhan pasien :
..
bukan stroke
tentukan jenisnya
SNH atau SH
Cara : - anamnesis
- algoritma dan penilaian dgn skor stroke
- pemeriksaan dgn menggunakan alat
Ri s k F
a c t or
Ma n a
g em e
nt
Stroke Prevention
Risk Factors1
Non modifiable
Age
Race
Gender
Family history of stroke.
Risk Factors-2
Modifiable / treatable
ANAMNESIS
Tabel 1. Perbedaan stroke hemoragik dan stroke infark
Gejala
(symptom)
-Onset/awitan
-Saat onset
-Peringatan
-Nyeri kepala
-Kejang
-Muntah
-Penurunan
kesadaran
Stroke hemoragik
Mendadak
Sedang aktif
(-)
+++
(+)
(+)
+++
Stroke
infark
Mendadak
Istirahat
(+)
(-)
(-)
Stroke
Stroke non
hemoragik
hemoragik
Sedang aktif
Istirahat
Peringatan (warning)
Nyeri kepala
+++
Kejang
Muntah
Stroke Hemoragik
Stroke Non
Hemoragik
Bradikardi
++ (dari awal)
(hari ke-4)
Udem papil
Sering +
Kaku kuduk
Tanda Kernig,Brudzinski
++
KURANG
DARAH
KECACATAN
PUSAT
KESADARAN
TIDAK SADAR
PUSAT NAFAS
PUSAT JANTUNG
KEMATIAN
A.
KECACATAN
SUMBATAN / EMBOLUS
DAERAH
MATI
B.
C.
D.
PENEBALAN DINDING
DAERAH PENUMBRA
(DAERAH SETENGAH MATI)
HARUS DISELAMATKAN
DARAH KENTAL
FISIOTERAPI
KECACATAN DIKURANGI
SEMAKSIMAL MUNGKIN
Diagnosis Stroke
- Berdasarkan temuan klinis
- Pemeriksaan Penunjang
PEMERIKSAAN PENUNJANG
Tujuan :
-menegakkan diagnosis
-mencari faktor risiko
-mencari faktor penyulit
LABORATORIUM
1. DARAH
- Rutin
- Hematokrit
- Masa perdarahan dan pembekuan
- Gula Darah I / II
- Kolesterol total, HDL, LDL
- Trigliserid
- Asam urat
- Ureum , Kreatinin
- Elektrolit
- Khusus : - Agregasi trombosit Homocysteine
Fibrinogen
- APTT
- D-dimer
- Protein C dan S
2. LUMBAL PUNGSI
- perdarahan sub arahnoid
3. X- FOTO TORAKS
- besar jantung, penyakit paru
4. EKG
- fibrilasi atrium, iskemik/infark jantung
EKOKARDIOGRAFI
- sumber emboli di jantung dan aorta proksimal
5. NEUROSONOGRAFI
- stenosis, vaso spasme
6. ANGIOGRAFI SEREBRAL
- AVM, anuerisma
Pemeriksaan Neuroimajing/neurosonologi
(NINS) selain dengan CT Scan & MRI ialah
dengan Angiografi serebral, PET, SPECT, dan
sonografi dopler (Transcranial Doppler
Sonography = TCDS) untuk mendeteksi
stenosis vaskular ekstra dan intrakranial
untuk membantu evaluasi diagnostik,
etiologik, terapetik dan prognostik
KEUNTUNGAN TCD
EFFEKTIVE
MUDAH DIGUNAKAN
NON-INVASIVE
NON-RADIO AKTIVE
PORTABLE
MURAH
DAPAT DIULANG DAN AMAN
KEKURANGAN TCD
KEGUNAAN TCD :
Kelebihan :
1. Non invasive
2. Banyak potongan yg dpt dilakukan secara langsung
3. Dgn akurat sangat tinggi
hampir semua jaringan
4. Tdk memakai sinar-X
5. Tdk merusak keshehatan pd penggunaannya yg tepat
6. Banyak pekerjaan yg dpt dikerjakan tanpa zat kontras
7. Potongan yg dihasilkan dpt 3 dimensi (aksial, frontal,
dan sagital) dan malah banyak potongan dapat dibuat
hanya dlm datu waktu (dpt membuat > 8 potongan
sekaligus)
Kekurangan :
1.Tdk
dpt
digunakan
u/penderita
gawat
darurat/darurat akut, yg non koperatif / anakanak karena pem ini memerlukan wkt yg lama,
dan alat-alat bantu yg bersifat ferromagnetik
tdk dpt masuk ke ruang pemeriksaan (gantry)
2. Sementara pemeriksaan berlangsung ada
suara gaduh
3. Biaya pemeriksaan dan pemeliharaan lebih
tinggi dari biaya pemeriksaan radiologi lainnya.
PENANGANAN STROKE
5
B
Penanganan Stroke Akut
Penanganan Faktor risiko
Penanganan Komplikasi
Rehabilitasi
Penanganan Post Stroke
1. No antihypertensives *,
2. No diuretics,
3. No dexamethasone,
4. No glucose infusion,
5. No anticoagulant 4 hours after onset
of stroke.
Hypoglycemia
Post-ictal state
Drug overdose
Encephalopathies with focal signs
Hyponatremia
Subdural hematoma/empyema
Concussion with neck injury
Facial nerve palsy!
Migraineous accompaniment.
74-year old.
2 hours after onset
BP 155/70
Normal platelets, etc.
.t-PA administered
Stuporous after 9 hrs.
Re-CT bleeding
Intravenous Pentoxyfilline.
Reperfusion injury.
In the presence of disruption of the
BBB, reperfusion may induce cerebral
edema and hemorrhage.
After a prolonged period of occlusion
leading to cellular injury: reperfusion
may result in increased production of
free radicals, gene expression and
inflammatory events augmentation
of cellular damage.
LMWH.
Usually not used as monotherapy.
Personal preference: give together with
another drug to selected stroke patients.
Start early, continue for 5-7 days.
Avoid LMWH if:
- systolic blood pressure > 180 mmHg.
- very large infarct or even a tiny bleed.
LMWH.
Usually not used as monotherapy.
Personal preference: give together with
another drug to selected stroke patients.
Start early, continue for 5-7 days.
Avoid LMWH if:
- systolic blood pressure > 180 mmHg.
- very large infarct or even a tiny bleed.
Cerebral edema.
May develop acutely, usually after second
day.
Strict attention to fluid balance, avoid the use
of hypotonic solutions, such as 5% glucose.
Use mannitol with caution.
Albumin, 25% solution, helpful, especially if
serum albumin < 3.6 g/dl.
Surgical help in case everything else fails.
Fever.
Electrolyte imbalance.
Bad for recovery, may be lifethreatening!
Repeat electrolyte test as often as
needed.
Treat promptly, do not rely on clinical
judgment alone!
Enlist the help of a good internist.
Proceed with caution, do not over-treat.
Malnutrition.
Remember to feed the patient!
Fluid infusions alone is not enough.
Starvation is very bad for the patient.
A well balanced diet is important to
the patients recovery.
Laboratory tests may help to
determine the patients nutritional
status.
Convulsions.
Occur in approximately 10-20% of stroke
patients, especially those with large
infarct.
Use parenteral dilantin except if contraindicated.
Oral route is too slow!
Control drug level and possible side
effects.
Routine administration of an
anticonvulsant is not recommended.
Increased level of
Homocysteine.
Harmful effects due to impairment of
endothelial
function through production of hydrogen
peroxide and consumption of NO to form
nitrosohomocysteine.
Aggravates atherosclerosis and coagulation.
Provokes neuropathy, retinopathy,
nephropathy
and cerebral vasospasm in SAH
Homocysteine-2
BLOOD PRESSURE
MANAGEMENT IN ICH (Broderick
1999)
Labetolol: 5-100 mg/h by intermittent bolus doses of 10-40 mg or continuous drip (2-8
mg/min).
Esmolol: 500 g/kg as a load, maintenance use, 50-200 g/kg/min.
Hydralazine: 10-20 mg Q 4-6 h
Enalapril: 0.625-1.2 mg Q 6 h as needed.
MANAGEMENT OF ICP
(Broderick 1999)
Osmotherapy:
- Mannitol 20% (0.25-0.5 g/kg every 4 h), for only 5 d.
- Furosemide (10 mg Q 2-8 h) simultaneously with mannitol.
- Serum osmolality 310 mOsm/L, measured 2 X daily.
No steroid
Hyperventilation:
- Reduction of pCO2 to 35-30 mm Hg, by raising ventilation
rate at constant tidal volume (12-14 mL/kg), lowers ICP 25%30%.
Muscle relaxants:
- Neuromuscular paralysis in combination with adequate
sedation can reduce elevated ICP.
- Vecuronium or pancuronium, with only minor histamine
liberation and ganglion-blocking effects are preferred.
RECOMMENDATIONS FOR
SURGICAL TREATMENT OF ICH
(Broderick 1999)
MANAGEMENT OF SAH
(1)
1. BEDREST
2. PREVENTION OF REBLEEDING
3. PREVENTION OF VASOSPASM
- Hypertension/hypervolemia/hemodilition (experimental)
- Calcium ch.antagonists : Nimodipine 6 X 60 mg p .o./infuse 1-2 mg/hr for
5-14 ds.
- Intracisternal fibrinolysis +antioxidant+ antiinflammatory agents
uncertain value
- Transluminal angioplasty in whom conventional therapy has failed.
MANAGEMENT OF SAH
(2)
4. HYDROCEPHALUS
5. PREVENTION OF HYPONATREMIA
6. PREVENTION OF SEIZURES
7. SURGICAL INDICATION
- RUPTURED ANEURYSMS
WFNS grade 1-3 (good-intermediate grade) surgery strongly indicated.
- UNRUPTURED ANEURYSMS
Surgery recommended
- ASYMPTOMATIC ANEURYSMS
> 1 cm operate; < 1 cm do not operate (consensus).
Yin Yang